Table III.

Univariate analysis and multivariate analysis for uteri corpus endometrial carcinoma according to overall survival.

A, Univariate analysis
Clinical characteristics	HR (95% CI)	P-value
SCGB2A1 expression	0.75 (0.71-0.80)	<0.001
Age at diagnosis	1.03 (1.00-1.05)	0.007
Race	0.95 (0.66-1.36)	0.769
Menopause status	0.68 (0.37-1.26)	0.221
Surgical approach	0.85 (0.52-1.37)	0.499
Histological type	0.60 (0.37-0.96)	0.033
Grade	3.49 (2.12-5.75)	<0.001
Tumor invasion depth	2.43 (1.56-3.87)	<0.001
Tumor status	6.85 (4.57-10.26)	<0.001
Residual tumor	2.65 (1.54-4.55)	<0.001
Peritoneal washing	3.05 (1.85-5.04)	<0.001
Pelvic lymph node metastasis	4.50 (2.87-7.05)	<0.001
Para-aortic lymph node metastasis	3.70 (2.11-6.49)	<0.001
Stage	1.80 (1.51-2.15)	<0.001
B, Multivariate analysis
Clinical characteristics	HR (95% CI)	P-value
SCGB2A1 expression	0.77 (0.69-0.86)	<0.001
Age at diagnosis	1.05 (1.01-1.10)	0.021
Tumor status	5.06 (2.10-12.17)	<0.001
Pelvic lymph node	4.57 (1.73-12.03)	0.002

HR, hazard ratio; CI, confidence interval; SCGB2A1, secretoglobin family 2A member 1.